CD38 deletion of human primary NK cells eliminates daratumumab-induced fratricide and boosts their effector activity

Multiple myeloma (MM) is a plasma cell neoplasm that commonly expresses CD38. Daratumumab (DARA), a human monoclonal antibody targeting CD38, has significantly improved the outcome of patients with relapsed or refractory MM, but the response is transient in most cases. Putative mechanisms of subopti...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Blood
Päätekijät: Naeimi Kararoudi, Meisam, Nagai, Yuya, Elmas, Ezgi, de Souza Fernandes Pereira, Marcelo, Ali, Syed Abbas, Imus, Philip Hollingsworth, Wethington, Darren, Borrello, Ivan Marques, Lee, Dean Anthony, Ghiaur, Gabriel
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Hematology 2020
Aiheet:
Immunobiology and Immunotherapy
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7685207/
https://ncbi.nlm.nih.gov/pubmed/32603414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2020006200
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia